VI Malaga Conference on Alzheimer’s

15 May 2019

16:00 – 20:30 COMPREHENSIVE APPROACH TO BEHAVIORAL DISORDERS IN DEMENTIA
Dr. José María García-Alberca, Psychiatrist. Clinical Psychologist. Alzheimer Treatment and Research Center, Andalusian Institute for Neuroscience (IANEC), Malaga.

Program

• Concept, classification and diagnosis in the clinical practice of BPSD.
• Evaluation instruments.
• Pharmacological treatment: use, choice, dose, adverse effects, interactions.
• Non-pharmacological therapies.
• MPractical handling.

Cada uno de lo inscritos en el Curso will receive a free copy of the book: Alzheimer’s Disease. Non-pharmacological therapies for psychological and behavioral symptoms, written by Dr. José María García-Alberca.

15:30 – 16:00 Registration

16:00 – 17:45 WORKSHOP 1
Update on aphasia. New approaches for treatment.
Marcelo Berthier, Centro de Investigaciones Médico-Sanitarias (CIMES), University of Málaga.

17:45 – 18:15 Coffee-Break

18:15 – 20:00 WORKSHOP 2
The importance of neuropsychology: beyond screening tests
Tamara Marín, Andalusian Institute for Neuroscience (IANEC), Malaga.

08:45 – 10:00 SESSION: CHALLENGES AND PROGRESS IN EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE

Chair: José Luis Royo, University of Málaga.

Use of genetics for the discovery of biomarkers and for revealing the genetic architecture of neurodegenerative disorders
Jordi Clarimón, Hospital de la Santa Creu i Sant Pau, Barcelona; CIBERNED.

GWAS in the Spanish population: the GRA@ACE/DEGESCO project.
Agustín Ruiz,Fundació ACE, Barcelona; CIBERNED.

Neuropsychological biomarkers for the detection of cognitive changes in preclinical Alzheimer’s disease.
Cristóbal Carnero Pardo, Hospital Universitario Virgen de las Nieves, Fidyan Neurocenter, Granada.

10:00 – 10:45 HOT TOPIC LECTURE

MOPEAD, Models of Patient Engagement for Alzheimer’s Disease.
Mercè Boada, Fundació ACE, Barcelona, CIBERNED.

Chair: José María García-Alberca, Andalusian Institute for Neuroscience (IANEC), Malaga.

10:45 – 11:15 Coffee-Break

11:15 – 12:30 SESSION: PATHOGENESIS OF ALZHEIMER’S DISEASE. WHAT HAVE WE LEARNED RECENTLY?

Chair: Natalia García-Casares, Universidad de Málaga.

Deciphering the implication of reactive astrocytes in Alzheimer’s disease: new pathogenic approach of therapeutic interest.
Antonia Gutiérrez Pérez, Institute of Biomedical Research of Málaga (IBIMA), University of Málaga.

Towards a transcriptomic definition of the microglial response in Alzheimer’s disease: differences between animal models and patients.
Javier Vitorica Ferrández. Seville Biomedical Institute (IBIS), University of Seville.

The impact of tau pathology on Alzheimer’s disease. Opportunities for a therapeutic intervention.
Miguel Medina, CIBERNED, Reina Sofia Foundation, CIEN Foundation.

12:30 – 13:00 OFFICIAL OPENING

13:00 – 14:15 SESSION: INNOVATIVE STRATEGIES IN TREATMENT (I)
Chair: Fermín Mayoral, Malaga Biomedical Research Institute (IBIMA).

Modulation of the cannabinoid system: a new perspective for the treatment of Alzheimer’s disease.
Ángeles Martín Requero, Centro de Investigaciones Biológicas (CSIC), CIBERER, Madrid.

Nanoliposomes as a therapeutic tool for Alzheimer´s disease.
Francisco Wandosell, Severo Ochoa Molecular Biology Centre (CSIC), CIBERNED, Madrid.

Relationship between Hearing Loss and Cognitive Impairment: The Brain Listens.
 Elena Vila, Quiron Salud Hospital, Malaga.

16:00 – 16:45 HOT TOPIC LECTURE
The challenge of preventing dementia.
José Luis Molinuevo, Alzheimer’s Disease and Other Cognitive Disorders Unit, IDIBAPS, Hospital Clinic, Barcelona. Barcelona Beta Brain Research Center, Fundació Pasqual Maragall, Barcelona.

Chair: Tamara Marín, Andalusian Institute for Neuroscience (IANEC), Málaga.

16:45 – 18:00 SESSION: EMERGING CONCEPTS

Chair: Miguel Ángel Barbancho, University of Málaga.

Alterations of intestinal microbiota in Alzheimer’s disease. Clinical Evidence and Pathways to Follow.
Esteban Orenes, University of Murcia.

Altered Patterns and Sleep Loss as Risk Factors for Cognitive Impairment and Alzheimer’s Disease.
José Luis Cantero, Laboratory of Functional Neuroscience, Pablo de Olavide University, Seville.

Inflammatory reactivity in major surgery and cognitive impairment.
Pascual Sánchez-Juan, Marqués de Valdecilla University Hospital, Santander.

18:00 – 18:30 Coffee-Break

18:30 – 19:45 SESSION: GOOD TREATMENT AND DIGNITY IN THE CARE OF PEOPLE WITH DEMENTIA

Chair: Ángela García Cañete, Andalusian Confederation of Federations of Relatives of People with Alzheimer’s Disease and Other Dementias (ConFEAFA).

Needs and quality of life of people with dementia and their family carers.
Manuel Gonçalves Pereira, Universidade Nova de Lisboa, Portugal.

Pain and Unspoken Symptoms: The Other Dementia.
José Manuel Marín Carmona, Municipal Memory Program and Dementia, Malaga City Council.

Palliative care and quality care for people with advanced dementia.
José Antonio López Trigo, President of the Spanish Society of Geriatrics and Gerontology.

08:45 – 10:00 SSESSION: TECHNOLOGICAL AND SOCIO-SANITARY INNOVATIONS IN ALZHEIMER’S DISEASE AND OTHER DEMENTIAS.

Chair: Saray Hevilla, Andalusian Institute for Neuroscience (IANEC), Malaga.

SIIA Project: Comprehensive Outpatient Intervention Program.
Carolina López de Luis, Center of State Reference for Attention to People with Alzheimer’s Disease and other Dementias, Salamanca.

Design of spaces for people with Alzheimer’s disease.
Pablo Lara, Centre for Medical-Sanitary Research (CIMES), University of Malaga.

Non-pharmacological therapies. New approaches.
Manel Sánchez Pérez, Sagrat Cor Hospital, Martorell, Barcelona.

10:00 – 10:45 HOT TOPIC LECTURE

New perspectives on risk factors and pathogenic mechanisms in Alzheimer’s syndrome.
Ángel Cedazo, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.

Chair: Esther Gris, Andalusian Institute for Neuroscience (IANEC), Malaga.

10:45 – 11:15 Coffee-Break

11:15 – 12:00 HOT TOPIC LECTURE

Present and future of the biomarkers in Alzheimer’s disease.
Alberto Lleó, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona.

Chair: Carlos de Linares, Clínica de Memoria Dr. Linares, Málaga.

12:00 – 12:30 LECTURE

The role of behavioral impairment in preclinical diagnosis of dementia.
José María García-Alberca, Alzheimer Research Center and Memory Clinic, Andalusian Institute for Neuroscience (IANEC), Malaga.

12:30 – 13:45 SESSION: INNOVATIVE STRATEGIES IN TREATMENT (II)

Chair: Francisco Garzón, Hospital Clínico Virgen de la Victoria, Málaga.

Plasma exchange with albumin: Effectiveness on the amyloid concentrations and cognition in patients with Alzheimer’s disease.
Antonio Páez, Grifols, Barcelona, Mercé Boada, Fundació ACE, Barcelona, CIBERNED.

ALFA Study. First results and future perspectives.
Gonzalo Sánchez-Benavides, BarcelonaBeta Brain Research Center, Pasqual Maragall Foundation, Barcelona.

Immunotherapy against Alzheimer’s disease: abvac40, an active anti-aβ40 vaccine.
Pedro Pesini, Araclon Biotech, Zaragoza.

13:45 – 14:00 CLOSING CEREMONY

(*) They will have to send accreditation document.

(**) In order to attend the Pre-Conference Course it is necessary to be registered in the Conference. All course attendees will receive a free copy of the book: Alzheimer’s Disease. Non-pharmacological therapies for psychological and behavioural symptoms, written by Dr. José María García-Alberca.

Prices 21% VAT not included

BASES

Those interested in submitting poster communications should send an email attaching the poster ABSTRACT to info@ianec.es, including in the subject line the text “POSTER ABSTRACT”.
The abstract must be a maximum of 300 words and must include the following data: title, surname and first name of the authors, surname and first name of the contact person. City, province, postal code, country, contact telephone, contact Email and organization..

• The deadline for abstract submission is 22/04/2019.

• The maximum measurements will be 120 cm high X 90 cm wide. A maximum of three posters may be submitted by the same author.

• At least one of the authors of the poster must be registered at the Conference in order for the acceptance of the poster to be definitive. Irrespective of the above, if other authors of the poster wish to attend the Conference sessions, they must be registered at the Conference.

• Each accepted poster will receive a free copy of the book: Alzheimer’s Disease. Non-pharmacological therapies for psychological and behavioral symptoms, written by Dr. José María García-Alberca.